Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.
about
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre studyHomeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFVascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisDevelopment of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding siteAngiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrinsVEGF-Trap: a VEGF blocker with potent antitumor effects.Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisEndothelial Dysfunction and Inflammation: Immunity in Rheumatoid ArthritisKeratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin conditionTumors: wounds that do not heal-reduxNeuropilins: expression and roles in the epitheliumVascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound RepairZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF productionVascular endothelial growth factor (VEGF) expression in the subacromial bursa is increased in patients with impingement syndromeCapillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signalingAn in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels.Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.In vivo optical imaging of expression of vascular endothelial growth factor following laser incision in skin.Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries.In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment.In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin.Updates on the pathophysiology and management of acne rosacea.Recombinant human VEGF165b inhibits experimental choroidal neovascularizationPlatelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomasInfluence of host microvascular environment on tumour vascular endothelium.Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody.Expression of Angiogenic Factors in Psoriasis VulgarisIL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas.The Production IL-21 and VEGF in UVB-irradiated Human Keratinocyte Cell Line, HaCaTBinding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells.Evidence for altered Wnt signaling in psoriatic skin.The lymphatic system in health and disease.Tazarotene-induced gene 3 may affect inflammatory angiogenesis in psoriasis by downregulating placental growth factor expressionStimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.Tyrosine kinases in inflammatory dermatologic disease.Progress in understanding the immunopathogenesis of psoriasisDifferential expression of the angiogenesis growth factors in psoriasis vulgaris.Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
P2860
Q22000875-8CD7712E-95DF-47F7-BD56-77FECC31AA4EQ22253478-2EF3F5A7-05EE-4FC5-832A-7A58A4C2A7D8Q22305863-C38BD101-571B-4C26-974D-0B8B99AC65D6Q24302190-1B0BC4D2-3839-4D95-B7A9-68D92514B764Q24311459-D661FB64-F006-45D2-8A46-638ECACC1B76Q24535043-4B29EC9F-1AC2-4B7C-911E-A73AE346A643Q24684263-04216A3C-6046-4F28-AD16-A7DF272FAE68Q26749294-4FFB4E95-0B17-4239-8678-B4546633B205Q26822766-BCF9075B-9EF0-4DF6-A6C4-E4AFF98AD42AQ26853439-D6BE1F82-D810-4A5E-A952-DB491A248617Q26998786-339819C0-16C0-4845-8368-B888A999B873Q27023354-3487A1EA-0448-4084-B59F-FFB32710E4DCQ28115802-07042D5E-CA9B-4085-9D40-63F42CEEFBDDQ28201021-9E33850A-D5D0-4446-B36A-C9D29A8917A3Q28581719-DD1EDEEC-B486-40C1-9AE0-01D9F7F7B096Q30528295-0ACF0B91-3AB2-45AC-AE6D-0B358975BFA3Q30750084-9A860464-988D-475B-9D23-CAE510063D4EQ30779379-A071F9DB-86EB-4D45-A122-D0FC7E6A5D25Q30854194-715655CE-2AEE-4452-BF80-9FE40A22B23BQ30995019-0A65E629-B8E5-454C-929A-ACC7902521CCQ31155806-C5C3BC61-DF24-40E7-902E-5CB392CF4753Q33180622-6B6A869E-C876-48BE-8D99-B3F77C19696BQ33509787-A12FE530-D738-40A4-8055-00CEC7E8D6B7Q33541827-E9BC669B-774E-4A74-B7C6-2E2572F038B1Q33597254-76BCA9C4-7860-44DE-8A25-E50197BF4B42Q33655353-8184542B-10C0-4401-8CAC-EB78D2678042Q33657663-6C5AC6B5-29DB-489F-A534-85AEE2E00757Q33666312-E31A2957-7B53-4657-9F93-C60EE444BEB1Q33732911-82A2360F-32AA-4E3A-9E92-582282156BE0Q33818805-CCE58616-522E-42AE-A6EE-606521EE6C18Q33896416-A1F3E9AF-5572-4597-985B-53B67791854AQ33914373-424ED516-50EF-4AD3-B82B-8CAFA703CAB9Q33915311-1FF4C9B9-F2D0-41F9-A771-6B6A183D7CF0Q34015299-9E170055-40C9-4C53-8468-90B071AF85D3Q34054418-25F0A250-A23A-4CB8-9316-3ECCFB2E6359Q34161479-BEB2FFB9-7816-4C10-8A49-ECC3F932C501Q34166503-BF83F261-638B-4FF0-9BC8-0D729BD1322AQ34215381-4B25C7C3-1313-470D-AA2E-7EE02B271AAFQ34248544-F82C4960-4055-411D-B876-656F2FB2B074Q34384434-045D0A25-0988-4716-9375-8DFF675ED15D
P2860
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Overexpression of vascular per ...... nd its receptors in psoriasis.
@ast
Overexpression of vascular per ...... nd its receptors in psoriasis.
@en
type
label
Overexpression of vascular per ...... nd its receptors in psoriasis.
@ast
Overexpression of vascular per ...... nd its receptors in psoriasis.
@en
prefLabel
Overexpression of vascular per ...... nd its receptors in psoriasis.
@ast
Overexpression of vascular per ...... nd its receptors in psoriasis.
@en
P2093
P2860
P356
P1476
Overexpression of vascular per ...... nd its receptors in psoriasis.
@en
P2093
H F Dvorak
K P Claffey
R W Jackman
P2860
P304
P356
10.1084/JEM.180.3.1141
P407
P577
1994-09-01T00:00:00Z